Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum
Abstract Background The prevalence of non-medullary thyroid cancer (NMTC) is increasing worldwide. Although most NMTCs grow slowly, conventional therapies are less effective in advanced tumors. Approximately 5–15% of NMTCs have a significant germline...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer International Publishing
2021
|
Online Access: | https://hdl.handle.net/1721.1/133155 |